CRISPR Therapeutics (NASDAQ: CRSP) and Moderna (NASDAQ: MRNA) have much in common. They're both innovative biotechs working in relatively newer niches of this booming...
Nearly everyone likes an underdog. They're the ones who don't get the respect they deserve but often deliver pleasant surprises.Three Motley Fool contributors think...